Renal mucormycosis following COVID-19 treatment with immune modulators: A case report
Frontiers in Emergency Medicine
; 6(1), 2022.
Article
in English
| Scopus | ID: covidwho-1551963
ABSTRACT
Mucormycosis is an opportunistic fungal infection that occurs primarily in immunocompromised individuals, usually affecting the rhino-orbital areas followed by the lungs. This case report presents renal mucormycosis in a young man after COVID-19 pneumonia that escalates the need for regular follow-up of COVID-19 patients. Post-COVID-19 fungal infections are on a steep rise, and the increased use of steroids and immune modulators for COVID-19-associated immune dysregulation and cytokine syndrome increases the risk among patients treated for COVID-19. © 2022 Tehran University of Medical Sciences.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Case report
Language:
English
Journal:
Frontiers in Emergency Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS